–Creating multiple novel mechanism drug candidates for HCV and other viral diseases
–Designing inhibitors of all points in the HCV lifecycle in a unique assay system, guided by National Academy of Science member, virologist and immunologist, Dr. Frank Chisari
–Using fast and efficient “Click Chemistry” guided by Nobel Laureate and world-renowned chemist, Dr. Barry Sharpless
–With a lean virtual company structure under the management of Dr. Linda Pullan, with over 20 years of drug industry experience in big companies and small companies and consulting in drug discovery and business development
Multiple drug candidates with novel mechanisms of action identified and undergoing optimization
–
Tremendous pharma interest